ScholarIQanswers from OpenAlex

Glucocorticoids in the treatment of patients with primary focal segmental glomerulosclerosis and moderate proteinuria

PaperCitations, authors & open-access status

Glucocorticoids in the treatment of patients with primary focal segmental glomerulosclerosis and moderate proteinuria is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Glucocorticoids in the treatment of patients with primary focal segmental glomerulosclerosis and moderate proteinuria have?

ScholarIQcitation count

Glucocorticoids in the treatment of patients with primary focal segmental glomerulosclerosis and moderate proteinuria has 8 citations in the OpenAlex counts ScholarIQ stores.

When was Glucocorticoids in the treatment of patients with primary focal segmental glomerulosclerosis and moderate proteinuria published?

ScholarIQyear

Glucocorticoids in the treatment of patients with primary focal segmental glomerulosclerosis and moderate proteinuria has 2018 year in the ScholarIQ index.

What is the open-access status of Glucocorticoids in the treatment of patients with primary focal segmental glomerulosclerosis and moderate proteinuria?

ScholarIQoa status

Glucocorticoids in the treatment of patients with primary focal segmental glomerulosclerosis and moderate proteinuria has closed oa status in the ScholarIQ index.

What is the DOI of Glucocorticoids in the treatment of patients with primary focal segmental glomerulosclerosis and moderate proteinuria?

ScholarIQdoi

The DOI for Glucocorticoids in the treatment of patients with primary focal segmental glomerulosclerosis and moderate proteinuria is on the source record.

What is the PMID of Glucocorticoids in the treatment of patients with primary focal segmental glomerulosclerosis and moderate proteinuria?

ScholarIQpmid

The PMID for Glucocorticoids in the treatment of patients with primary focal segmental glomerulosclerosis and moderate proteinuria is on the source record.

What is the OpenAlex record for Glucocorticoids in the treatment of patients with primary focal segmental glomerulosclerosis and moderate proteinuria?

ScholarIQopenalex

The OpenAlex for Glucocorticoids in the treatment of patients with primary focal segmental glomerulosclerosis and moderate proteinuria is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial